HOME > 当科における教育・研究 > 業績
2010年
Third-line gemcitabine monotherapy for platinum-resistant advanced urothelial cancer.
Norihito Soga, Hideaki Kise, Kiminobu Arima, Yoshiki Sugimura
The International Journal of Clinical Oncology 15 : 376-381, 2010
Structural changes in alpha1-adrenoceptor antagonist-treated human prostatic stroma.
Tetsuya Imamura, Kenichiro Ishii, Hideki Kanda, Shigeki Arase, Yuko Yoshio, Yasuhide Hori, Norihito Soga, Hideaki Kise, Kiminobu Arima, Yoshiki Sugimura
Clinical and experimental medicine 10(2) : 99-106, 2010
Effect of transforming growth factor α overexpression on urogenital organ development in mouse.
Yuko Yoshio, Kenichiro Ishii, Shigeki Arase, Yasuhide Hori, Kohei Nishikawa, Norihito Soga, Hideaki Kise, Kiminobu Arima, Yoshiki Sugimura
Differentiation 80(2-3) : 82-88, 2010
Risk Factors Contributing to the Development of Hypocalcemia after Zoledronic Acid Administration in Patients with Bone Metastases of Solid Tumor.
Miho Hanamura, Takuya Iwamoto, Norihito Soga, Yoshiki Sugimura, Masahiro Okuda
Biological & Pharmaceutical Bulletin 33(4) : 721-724, 2010
Midterm results of radiofrequency ablation versus nephrectomy for T1a renal cell carcinoma.
Haruyuki Takaki, Koichiro Yamakado, Shigeki Kobayashi, Atsuhiro Nakatsuka, Junji Uraki, Masataka Kashima, Norihito Soga, Kiminobu Arima, Kan Takeda, Yoshiki Sugimura
Japanese Journal of Radiology 28 : 460-468, 2010
Endodermal origin of bladder trigone inferred from mesenchymal-epithelial interaction.
Stacy T Tanaka, Kenichiro Ishii, Romano T Demarco, John C Pope, John W Brock, Simon W Hayward
The Journal of Urology 183(1) : 386-391, 2010
2009年
Complications of Radiofrequency Ablation and Cryoablation for small RCC.
Kiminobu Arima, Kouichirou Yamakado, Norihito Soga, Hideaki Kise, Kan Takeda, Yoshiki Sugimura
Recent Advances in Endourology 11 : 131-136, 2009
Gemcitabine / Capecitabine therapy as a second-line treatment for advanced immunotherapy resistant renal cell cancer in Japanese cases.
Norihito Soga, Yasushi,Yamada Kouhei Nishikawa, Yoshihiro Hasegawa, Hideaki Kise, Kiminobu Arima, Yoshiki Sugimura
International Journal of Urology 16(6) : 576-9, 2009
Intermittent docetaxel with estramustine in hormone refractory prostate cancer in Japanese cases.
Norihito Soga, Manabu Katou, Yoshihiro Hasegawa, Kouhei Nishikawa, Yasushi Yamada, Hideaki Kise, Kiminobu Arima,Sugimura Yoshiki
International Journal of Clinical Oncology 14(2) ： 130-5, 2009
Evidence that androgen-independent stromal growth factor signals promote androgen-insensitive prostate cancer cell growth in vivo.
Ishii Kenichiro, Imamura Tetsuya, Iguchi Kazuhiro, Arase Sshigeki, Yoshio Yuko, Arima Kiminobu, Hirano Kazuyuki, Sugimura Yoshiki
Endocrine Related Cancer 16(2) : 415-428, 2009
Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma.
Norihito Soga, Koichiro Yamakado, Hideo Gohara, Haruyuki Takaki, Takao Hiraki, Tomomi Yamada, Kiminobu Arima, Kan Takeda, Susumu Kanazawa, Yoshiki Sugimura
British Journal of Urology International 104（6）：790-794, 2009
Adult urothelial transdifferentiation to prostate epithelia is mediated by paracrine TGF-s signaling.
Li X, Wang Y, Sharif-Afshar AR, Uwamariya C, Yi A, Kenichiro Ishii, Hayward SW, Matusik RJ, Bhowmick NA.
Differentiation 77：95-102, 2009
2008年
Adjuvant M-VAC (methotrexate, vinblastine,adriamycin and cisplatin) chemotherapy prevent recurrent of bladder tumors after operation in upper urinary tract transitional cell carcinoma.
Norihito Soga, Kiminobu Arima, Yoshiki Sugimura
International Journal of Urology 15(9) : 800-803, 2008
Comparison of radical nephrectomy under the minimal incision with portless endscopic surgery (PLES) versus transperitonial laparoscopic surgery.
Norihito Soga, Manabu Kato, Yoshihiro Hasegawa, Kouhei Nishikawa, Yasushi Yamada, Hideaki Kise, Kiminobu Arima, Yoshiki Sugimura
International Journal of Urology 15 : 1018-1021, 2008
Undetectable level of prostate specific antigen (PSA) nadir predicts PSA biochemical failure in local prostate cancer with delayed-combined androgen blockade.
Norihito Soga, Kiminobu Arima, Yoshiki Sugimura
Japanese Journal of Clinical Oncology 38 : 617-622, 2008
Role of stromal tenascin-C in mouse prostatic development and epithelial cell differentiation.
Kenichiro Ishii, Kyoko Imanaka-Yoshida, Toshimichi Yoshida, Yoshiki Sugimura
Developmental Biology 324 : 310-319, 2008
Improvement to predict tumorigenic phenotype of androgen-insensitive human LNCaP prostatic cancer cell subline in recombination with rat urogenital sinus mesenchyme.
Masahiro Kanai, Kenichiro Ishii, Hideki Kanda , Yuji Ogura, Hideaki Kise, Kiminobu Arima, Yoshiki Sugimura
Cancer Science 99(12) : 2435-2443, 2008
Naftopidil, a selective a-1 adrenoreptor antagonist, inhibits growth of human prostate cancer cells by G1 cell cycle arrest.
Hideki Kanda, Kenichiro Ishii, Yuji Ogura, Tetsuya Imamura, Masahiro Kanai, Kiminobu Arima, Yoshiki Sugimura
International Journal of Cancer 122 : 444-451, 2008
Photoselective vaporization of the prostate using high power (80 W) KTP laser
: one year follow up of the first 101 patients in Japan.
Yasuhide Hori, Isao Kuromatsu, Yoshiki Sugimura
International Journal of Urology 15(12) : 1067-1071, 2008
Lack of involvement of the GNAS1 T393C polymorphism in prostate cancer risk in a Japanese population.
Masatoshi Watanabe, Yoshifumi Hirokawa, Mayumi Tsuji, Masato Yanagawa, Tetsuya Murata, Hiroyoshi Suzuki, Tomohiko Ichikawa, Takahiko Katoh, Yohsiki Sugimura, Taizo Shiraishi
Anticancer Research 28(6A) : 3711-3716, 2008
2007年
Image-guided radiofrequency ablation for adrenocortical adenoma with Cushing syndrome:Outcomes after mean follow-up of 33 months.
Kiminobu Arima, Kouichirou Yamakado, Ryuichi Suzuki, Hiroshi Matsuura, Atsuhiro Nakatsuka, Kan Takeda, Yoshiki Sugimura
Urology 70 : 407-411, 2007
Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: Results at 2-year mean follow-up.
Kiminobu Arima, Kouichirou Yamakado,Hiroyuki Kinbara, Atsuhiro Nakatsuka, Kan Takeda, Yoshiki Sugimura
International Journal of Urology 14 : 585-590, 2007
Bisphenol A induces permanent squamous change in mouse prostatic epithelium
Yuji Ogura, Kenichiro Ishii, Hideki Kanda, Masahiro Kanai, Kiminobu Arima, Wang YZ, Yoshiki Sugimura
Differentiation 75 : 745-756, 2007
Proprotein convertases modulate budding and branching morphogenesis of rat ventral prostate.
Katsunori Uchida, Masahiro Kanai, Shigenori Yonemura, Kenichiro Ishii, Yoshifumi Hirokawa, Yoshiki Sugimura
International Journal of Developmental Biology 51 : 229-233, 2007
Prostate-specific antigen half-life and pretreatment prostate-specific antigen :Crucial predictors for prostate-specific antigen trend in delayed-combined androgen blockade therapy.
Norihito Soga, Takehisa Onishi, Kiminobu Arima, Yoshiki Sugimura
International Journal of Urology 14(3) : 192-197, 2007
Paclitaxel Carboplatin chemotherapy as a second-line chemotherapy for advanced platinum resistant urothelial cancer in Japanese cases.
Norihito Soga, Takehisa Onishi, Kiminobu Arima, Yoshiki Sugimura
International Journal of Urology 14(9) : 828-832, 2007
Isolation and Characterization of LNCaP Sublines Differing in Hormone Sensitivity.
Kazuhiro Iguchi, Kenichiro Ishii, Nakano Toru, Takashi Otsuka, Shigeyuki Usui, Yoshiki Sugimura, Kazuyuki Hirano
Journal of Andrology 28(5) : 670-678, 2007
Assesment of Health-related Quolity of Life after Radiofrequency Ablation or Laparoscopic Surgery for Small Renal CellCarcinoma : a Prospective Study with Medical Outcomes Study 36-Item Health Survey(SF-36).
Takehisa Onishi, Kouhei Nishikawa, Yoshihiro Hasegawa, Yasushi Yamada, Norihito Soga, Kiminobu Arima, Kouichiro Yamakado, Akira Hoshina ,Yoshiki Sugimura
Japanese Journal of Clinical Oncology 37 : 750-4, 2007
Global update on defining and treating high-risk localized prostate cancer with leuprorelin : an Asian perspective.
Atsushi Mizokami, Satoshi Ueno, Takashi Fukagai, Kazuto Ito, Hidetoshi Ehara, Hiroyuki Kinbara, Hideki Origasa, Michiyuki Usami, Mikio Namiki, Hideyuki Akaza
Britishi Journal of Urology International 99 Suppl 1 : 6-9, discussion 17-8, 2007
Early tumor regression following severe lung injury after allogeneic stem cell transplantation in a patient with renal cell carcinoma.
Natsuki Hoshino, Kazunori Nakase, Isao Tawara, Shinichi Kageyama, Kohshi Ohishi, Yoshiki Sugimura, Hiroshi Shiku, Noriyuki Katayama
Internal Medicine 46(6) : 291-3, 2007
Intracellular localization of protein C inhibitor(PCI) and urinary plasminogen activator in renal tubular epithelial cells from humans and human PCI gene transgenic mice.
Zhenhu Song, Ning Ma, Tatsuya Hayashi, Esteban C.Gabazza, Yoshiki Sugimura, Koji Suzuki
Histochemistry and Cell Biology 128 : 293-300, 2007
2006年
Ureteral obstruction associated with pelvic inflammatory disease in a long-term intrauterine contraceptive device user.
Shigenori Yonemura, Mitsuhiko Moriya, Yasuhide Hori, Kiminobu Arima, Nagayasu Toyoda, Yoshiki Sugimura
International Journal of Urology 13(3) : 315-7, 2006
Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm : initial experience.
Kouichiro Yamakado, Atsuhiro Nakatsuka, Shigeki Kobayashi, Masao Akeboshi, Haruyuki Takagi, Zentaro Kariya, Hiroyuki Kinbara, Kiminobu Arima, Makoto Yanagawa, Yasuhide Hori , Hiromi Kato, Yoshiki Sugimura, Kan Takeda
Cardiovascular and Interventional Radiolgy 29(3) : 389-94, 2006
Steroid hormones stimulate human prostate cancer progression and metastasis.
Ricke WA, Kenichiro Ishii, Ricke EA, Simko J, Wang Y, Hayward SW, Cunha GR
International Journal of Cancer 118(9) : 2123-31, 2006
Androgen dependent prostate epithelial cell selection by targeting ARR2PBneo to the mouse prostate Lab Invest.
Wang Y, Kasper S, Yuan J, Jin RJ, Zhang J, Kenichiro Ishii, Wills ML, Hayward SW, Matusik RJ
Laboratory Investigation 86(10) : 1074-88, 2006
2005年
Treatment option for pT3 patient after radical prostatectomy.
Yoshiki Sugimura, Toshiaki Wakita, Atsushi Mizogami
Hinyokika Kiyo 51(9) : 571-3, 2005
Down-regulation of Skp2 is correlated with p27-associated cell cycle arrest induced by phenylacetate in human prostate cancer cells.
Takuji Shibahara, Takehisa Onishi, Franco OE, Kiminobu Arima, Yoshiki Sugimura
Anticancer Research 25(3B) : 1881-8, 2005
Natural history of human prostate gland : Morphometric and histopathological analysis of Japanese men.
Shinji Fujikawa, Hiroshi Matsuura, Masahiro Kanai, Miki Fumino, Kenichiro Ishii, Kiminobu Arima, Taizo Shiraishi, Yoshiki Sugimura
Prostate 65(4) : 355-64, 2005
Successful management of inferior vena cava thrombus complicating advanced germ cell testicular tumor with temporary inferior vena cava filter.
Satoru Masui, Takehisa Onishi, Kiminobu Arima, Yoshiki Sugimura
International Journal of Urology 12(5) : 513-5, 2005
Papillary adenocarcinoma of the renal pelvis and ureter producing carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 125.
Takehisa Onishi, Franco OE, Takuji Shibahara, Kiminobu Arima, Yoshiki Sugimura
International Journal of Urolgy 12(2) : 214-6, 2005
Use of tissue recombination to predict phenotypes of transgenic mouse models of prostate carcinoma.
Kenichiro Ishii, Shappell SB, Matusik RJ, Hayward SW
Laboratory Investigation 85(9) : 1086-103, 2005
Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation.
Gao N, Kenichiro Ishii, Mirosevich J, Kuwajima S, Oppenheimer SR, Roberts RL, Jiang M, Yu X, Shappell SB, Caprioli RM, Stoffel M, Hayward SW, Matusik RJ
Development 132(15) : 3431-43, 2005
Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.
Williams K, Fernandez S, Stien X, Kenichiro Ishii, Love HD, Lau YF, Roberts RL, Hayward SW
Prostate 63(4) : 369-84, 2005
2004年
Zinc and Metallothionein Levels and Expression of Zinc Transporters in Androgen-Independent Subline of LNCaP Cells.
Kazuhiro Iguchi, Takashi Otsuka, Shigeyuki Usui, Kenichiro Ishii, Takehisa Onishi, Yoshiki Sugimura, Kazuyuki Hirano
Journal of Andology 25(1) : 154-161, 2004
Evidence that the prostate-specific antigen(PSA)/Zn２＋ axis may play a role in human prostate cancer cell invasion.
Kenichiro Ishii, Takashi Otsuka, Kazuhiro Iguchi, Shigeyuki Usui,Hajime Yamamoto, Yoshiki Sugimura, Kazuhiro Yoshikawa, Simon W.Hayward, Kazuyuki Hirano
Cancer Letters 15 207(1) : 79-87, 2004
Radical Cystectomy for Invasive Bladder Cancer : Results of Multi-institutional Pooled Analysis.
Atsushi Takahashi, Taiji Tsukamoto, Ken-ichi Tobisu, Nobuo Shinohara, Kazunari Sato, Yoshihiko Tomita, Shu-ichi Komatsubara, Osamu Nishizawa, Tatsuo Igarashi, Hiroyuki Fujimoto, Hayakazu Nakazawa, Hideki Komatsu, Yoshiki Sugimura, Yoshinari Onomasa.
Japanese Clinical Oncology 34(1) : 14-19, 2004
Decreased expression of KAI1 metastasis suppressor gene is a recurrence predictor in primary pTa and pT1 urothelial bladder carcinoma.
Jing-Shi SU, Kiminobu Arima, Mariko Hasegawa, O.E.Franco, Yoshiki Umeda, Makoto Yanagawa, Yoshiki Sugimura, Juichi Kawamura
International Journal of Urology 11(2) : 74-82, 2004
Identification of differentially methylated CpG islands in prostate cancer.
Yasushi Yamada, Minoru Toyota, Yoshifumi Hirokawa, Hiroyoshi Suzuki, Akimitsu Takagi, Takeshi Matsuzaki, Yoshiki Sugimura, Ryuichi Yatani, Taizo Shiraishi, Masatosi Watanabe
International Journal of Cancer 10 112(5) : 840-5, 2004
Genetic polymorphisms of hormone-related genes and prostate cancer risk in the Japanese population.
Takahide Fukatsu, Yoshifumi Hirokawa, Tomio Araki, Takuichi Hioki, Murata T, Hiroyoshi Suzuki, Tomohiko Ichikawa, Hiromasa Tsukino, Qiu D, Takahiro Katoh, Yoshiki Sugimura, Ryuichi Yatani, Taizo Shiraishi, Masatoshi Watanabe
Anticancer Research 24(4) : 2431-7, 2004
Radiofrequency ablation combined with selective renal arterial embolization of small renal cell carcinoma : Early experience.
Kiminobu Arima, Hiroyuki Kinbara, Kouichurou Yamakado, Atsuhiro Nakatsuka, Kan Takeda, Hiromi Kato, Yoshiki Sugimura
Journal of Urology 171(4) : 342-343, 2004
Radiofrequency ablation combined with selective renal arterial embolization of renal cell carcinoma.
Kiminobu Arima, Hiroyuki Kinbara, Kouichiro Yamakado, Asuhiro Nakatsuka, Kan Takeda, Hiromi Kato, Yoshiki Sugimura
British Journal of Urology International 94(2) : 283, 2004
Comparison of cyclosporine concentrations in renal transplant recipients using ACMIA and mFPIA methods.
Yoshiki Kagawa, Makoto Yanagawa, Youichi Muraki, Takuya Iwamoto, Hideki Mizutani, Yoshiki Sugimura, Michio Kojima
Clinical Biochemistry 37 : 1016-1021, 2004
Radical cystectomy for invasive bladder cancer: results of multi-institutional pooled analysis.
Atsushi Takahashi, Taiji Tsukamoto, Kenichi Tobisu, Nobuo Shinohara, Kazunari Sato, Yoshihiko Tomita, Shuichi Komatsubara , Osamu Nishizawa, Tatsuo Igarashi, Hiroyuki Fujimoto, Hayakazu Nakazawa, Hideki Komatsu, Yoshiki Sugimura, Yoshinari Ono, Masao Kuroda, Osamu Ogawa, Yoshihiko Hirao, Tadashi Hayashi, Tomoyasu Tsushima, Yoshiyuki Kakehi, Yoichi Arai, Shouichi Ueda, Masayuki Nakagawa
Japanese Journal of Clinical Oncology 34(1) : 14-9, 2004
Renal lymphoma associated with Castleman's disease.
Takehisa Onishi, Shigenori Yonemura, Yuko Sakata, Yoshiki Sugimura
Scandinavian Journal of Urology and Nephrology 38(1) : 90-91, 2004
Coexistence of renal replacement lipomatosis with xanthogranulomatous pyelonephritis.
Yuko Sakata, Nobutaka Kinoshita, Hiromi Kato, Yasushi Yamada, Yoshiki Sugimura
International Journal of Urology 11(1) : 44-46, 2004
Tuberculid of the penis with a scab on the nodule.
Shigenori Yonemura, Shinji Fujikawa, Su JS, Takehisa Onishi, Kiminobu Arima, Yoshiki Sugimura
International Journal of Urology 11(10) : 931-933, 2004
NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.
Jin RJ, Wang Y, Naoya Masumori, Kenichiro Ishii, Taiji Tsukamoto, Shappell SB, Hayward SW, Kasper S, Matusik RJ.
Cancer Research 64(15) : 5489-95, 2004
2003年
Proprotein convertases regulate activity of prostate epithelial cell differentiation markers and are modulated in human prostate cancer cells.
Katsunori Uchida, Chaudhary LR, Yoshiki Sugimura, Adkisson HD, Hruska KA
Journal of Cellular Biochemistry 88 : 394-399, 2003
Phenylacetate Inhibits Growth and Modulates Cell Cycle Gene Expression in Renal Cancer Cell Lines.
Omar E.Franco, Takehisa Onishi, Yoshiki Umeda, Norihito Soga, Toshiaki Wakita, Kiminobu Arima, Makoto Yanagawa, Yoshiki Sugimura
Anticancer Research 23 : 1637-1642, 2003
Down-regulated expression of prostasin in high-grade or hormone-refractory human prostate cancers.
Satoru Takahashi, Shugo Suzuki, Shingo Inaguma, Yoshihisa Ikeda, Cho YM, Norio Hayashi, Takahiro Inoue, Yoshiki Sugimura, Naoki Nishiyama, Tamio Fujita, Chao J, Toshikazu Ushijima, Tomoyuki Shirai
The Prostate 54 : 187-193, 2003
Mitogen-activated protein kinase pathway is involved in androgen-independent PSA gene expression in LNCaP cells.
Franco OE, Takehisa Onishi, Kensuke Yamakawa, Kiminobu Arima, Makoto Yanagawa, Yoshiki Sugimura, Jyuichi Kawamura
The Prostate 56(4) : 319-325, 2003
Proliferative status is a risk index for recurrence in primary superficial(pTa/T1) low-grade urothelial bladder carcinoma.
Jing-Shi Su, Kiminobu Arima, Mariko Hasegawa, O.E.Franco, Makoto Yanagawa, Yoshiki Sugimura, Juichi Kawamura
Acta Urologica Japonica 49 : 649-658, 2003
Pheochromocytoma of the urinary bladder without typical symptoms.
Takehisa Onishi, Yuko Sakata, Shigenori Yonemura, Yoshiki Sugimura
International Journal of Urology 10(7) : 398-400, 2003
2002年
Down-regulation of human X-box binding protein 1 (hXBP-1) expression correlates with tumor progression in human prostate cancers.
Satoru Takahashi, Shugo Suzuki, Shingo Inaguma, Yoshihisa Ikeda, Y-M Cho, Naoki Nishiyama, Tamio Fujita, Takahiro Inoue, Takuichi Hioki, Yoshiki Sugimura, Toshikazu Ushijima, Tomoyuki Shirai
The Prostate 50 : 154-161, 2003
Down-regulation of Lsm1 is involved in human prostate cancer progression
Satoru Takahashi, Sshugo Suzuki, Shingo Inaguma, Y-M Cho, Yoshihisa Ikeda, Norio Hayashi, Takahiro Inoue, Yoshiki Sugimura, Naoki Nishiyama, Tamio Fujita, Toshikazu Ushijima, Tomoyuki Shirai
British Journal of Cancer 86 : 940-946, 2003
Preoperative predictors of cancerous involvement of the neurovascular bundles in patients with localized prostate cancer.
Takahiro Inoue, Takuichi Hioki, Norio Hayashi, Satoru Takahashi, Tomoyuki Shirai, Yoshiki Sugimura
International Journal of Urology 9 : 47-53, 2003
Ureteroarterial fistula controlled by intraluminal ureteral occlusion.
Takahiro Inoue, Takuichi Hioki, Yoichi Arai , Yoshitaka Inaba, Yoshiki Sugimura
International Journal of Urology 9 : 120-121, 2003
NAD(P)H : quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese.
Nobuyuki Hamajima, Keitaro Matsuo,Hiroji Iwata, Masayuki Shinoda, Yoshitaka Yamamura, Tomoyuki Kato, Shunzo Hatooka, Tetsuya Mitsudomi, Motokazu Suyama, Yoshitoyo Kagami, Michinori Ogura, Manabu Ando, Yoshiki Sugimura, Kazuo Tajima
International Journal of Clinical Oncology 7 : 103-108, 2002
High-Level Expression of Zinc Transporter-2 in the Rat Lateral and Dorsal Prostate.
Kazuhiro Iguchi, Shigeyuki Usui, Takahiro Inoue, Yoshiki Sugimura, Masae Tatematsu, Kazuyuki Hirano
Journal of Andorology 23 : 819-824, 2002
Ureteroarterial fistula controlled by intraluminal ureteral occlusion : a case report.
Takahiro Inoue, Takuichi Hioki, Yoichi Arai, Yoshitaka Inaba, Yoshiki Sugimura
International Journal of Urology 9 : 120-121, 2002
2001年
Aminopeptidase N regulated by zinc in human prostate participates in tumor cell invasion.
Kenichiro Ishii, Shigeyuki Usui, Yoshiki Sugimura, Sei Yoshida, Takuichi Hioki, Masae Tatematsu, Hajime Yamamoto, Kazuyuki Hirano
International Journal of Cancer 92 : 49-54, 2001
An anterior urethral stitch improves urinary incontinence following radical prostatectomy.
Yoshiki Sugimura, Takuichi Hioki, Yasushi Yamada, Miki Fumino, Takahiro Inoue
International Journal of Urology 8 : 153-157, 2001
Decreases of metallothionein and aminopeptidase N in renal cancer tissues.
Kenichiro Ishii, Shigeyuki Usui, Hajime Yamamoto, Yoshiki Sugimura, Masae Tatematsu, Kazuyuki Hirano
Journal of Biochemistry 129 : 253-258, 2001
Extract from Serenoa repens suppresses the invasion activity of human urological cancer cells by inhibiting urokinase-type plasminogen activator.
Kenichiro Ishii, Shigeyuki Usui, Yoshiki Sugimura, Hajime Yamamoto, Kazuhiro Yoshikawa, Kazuyuki Hirano
Biological & Pharmaceutical Bulletin 24 : 188-190, 2001
Inhibition of aminopeptidase N (AP-N) and urokinase-type plasminogen activator (uPA) by zinc suppresses the invasion activity in human urological cancer cells.
Kenichiro Ishii, Shigeyuki Usui, Yoshiki Sugimura, Hajime Yamamoto, Kazuhiro Yoshikawa, Kazuyuki Hirano
Biological & Pharmaceutical Bulletin 24 : 226-230, 2001
Real time reverse transcriptase polymerase chain reaction of urinary cytokeratin 20 detects transitional cell carcinoma cells.
Takahiro Inoue, Hayao Nakanishi, Kenichi Inada, Takuichi Hioki, Masae Tatematsu, Yoshiki Sugimura
Journal of Urology 166 : 2134-2141, 2001
